Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
News today Hemp/Digipath agreement
https://finance.yahoo.com/news/digipath-three-potency-testing-laboratories-140000732.html?.tsrc=applewf
Possibility of CGC buyout
With the recent news of Canopy Growth CGC obtaining the hemp license in NY state and establishing commercial operations in the US, couldnt there be a possible buyout of hemp, inc if they wanted to expand their operations in the US? The hemp market could get very competitive now that the Farm Bill has been signed
Proprietary Industrial Hemp Strains
Great read for new Hemp Inc. investors:
https://globenewswire.com/news-release/2018/05/31/1514851/0/en/Hemp-Inc-Announces-Creation-of-Proprietary-Industrial-Hemp-Strains-as-U-S-Senate-Supports-Cannabis-Seed-Bank.html
Hemp CBD companies rdmag article
https://www.rdmag.com/news/2019/01/advanced-studies-and-latest-innovation-helping-hemp-cbd-companies-increase-yields
$ADVM posted DD about it last week
when it was trading at $3.04-$3.10. nobody said
anything.
$GPL nice article on Great Panther
http://www.theaureport.com/cs/user/print/na/17049 fully stocked treasury, low operating costs, and meaningful silver production. Everything falling into place for this miner
$GPL good day and strong close
Still .19 below what Sport did deal for @ $1.60. weekly golden cross coming like AF mentioned. Long way to go. GL to all!
$ADVM Alert Cash Rich Low Float Biotech
ADVM has $247 million in cash and 0 debt, $9.56 cash/sh, $8.92 book/sh, 18.82M float. 90% of shares are held by insiders & funds. Institutional buying has increased 45% in last 3 months. 2 more catalysts before end of year. Nice pipeline of drugs. Closed Friday at only $3.23. check it out
$ADVM Super Cash Rich Biotech Flying Under Radar
ADVM has $247 million in cash and 0 debt, $9.56 cash/sh, $8.92 book/sh, 18.82M float. 90% of shares are held by insiders & funds. Institutional buying has increased 45% in last 3 months. 2 more catalysts before end of year. Nice pipeline of drugs. Closed Friday at only $3.23. check it out
$ADVM Super Cash Rich Biotech Flying Under Radar
ADVM has $247 million in cash and 0 debt, $9.56 cash/sh, $8.92 book/sh, 18.82M float. 90% of shares are held by insiders & funds. Institutional buying has increased 45% in last 3 months. 2 more catalysts before end of year. Nice pipeline of drugs. Closed Friday at only $3.23. check it out
$ADVM Cash Rich Biotech Flying Under Radar
ADVM has $247 million in cash and 0 debt, $9.56 cash/sh, $8.92 book/sh, 18.82M float. 90% of shares are held by insiders & funds. Institutional buying has increased 45% in last 3 months. 2 more catalysts before end of year. Nice pipeline of drugs. Closed Friday at only $3.23. check it out
$ADVM Top Pick Today Super Cash Rich Biotech
ADVM has $247 million in cash and 0 debt, $9.56 cash/sh, $8.92 book/sh, 18.82M float. 90% of shares are held by insiders & funds. Institutional buying has increased 45% in last 3 months. 2 more catalysts before end of year. Nice pipeline of drugs. Closed Friday at only $3.23. check it out
ADVM Super Cash Rich Low Float Biotech Alert
ADVM has $247 million in cash and 0 debt, $9.56 cash/sh, $8.92 book/sh, 18.82M float. 90% of shares are held by insiders & funds. Institutional buying has increased 45% in last 3 months. 2 more catalysts before end of year. Nice pipeline of drugs. Closed Friday at only $3.23. check it out
$ADVM Super Cash Rich Low Float Biotech
ADVM has $247 million in cash and 0 debt, $9.56 cash/sh, $8.92 book/sh, 18.82M float. 90% of shares are held by insiders & funds. Institutional buying has increased 45% in last 3 months. 2 more catalysts before end of year. Nice pipeline of drugs. Closed Friday at only $3.23. check it out
$ADVM interesting super-cash rich low float biotech
ADVM has $247 million in cash and 0 debt, $9.56 cash/sh, $8.92 book/sh, 18.82M float. 90% of shares are held by insiders & funds. Institutional buying has increased 45% in last 3 months. 2 more catalysts before end of year. Nice pipeline of drugs. Closed Friday at only $3.23. check it out
$GPL looks good today!
silver down today a GPL holding its own. another indication that it may have bottom. looks like it is consolidating now. very limited downside from here imo. Sprott's deal was at $1.60 a share. this is a bargain still!
$GPL I think it is very encouraging
I purchased a starter position today. I really like that Sprott Private Wealth was in on the recent deal. I'm not too concerned with the chart right now. Plan on holding for a while. It's going to be a definite winner imo
$GPL should Great Panther be on your radar?
http://finance.yahoo.com/news/great-panther-gpl-radar-now-124512596.html
$TGD to Post Q2 2016 Earnings of $0.04 Per Share
http://www.com-unik.info/timmins-gold-corp-tmm-to-post-q2-2016-earnings-of-0-04-per-share-national-bank-financial-forecasts/
Burp you are so right...
I was reading your posts on the lion. Perfectly stated and 100% correct about traffic stops. DRRX multi-bagger!
One Stop Shop for Gold/Silver Plays
You guys rock! Congrats Orions! Consistently
great calls here...
Gold/Silver Ratio
I think silver is a good play right now. The current
gold/silver ratio is extremely high right now. Once
silver gets through 18 I think it will do well. It seems
really undervalued right now with gold approaching 1400.
TGD-Joined you AF
not that many but in with ya
thanks AF
MGN-no premarket activity
anybody buying this? big insider purchase
recently and possible upcoming deal with HL.
maybe can snag some shares at the open
$AXU Bought in today
In for long haul and not selling
until over $1. GL to all!
ARO any concerns of .01 gap
left from thur-fri? all gaps get filled.
also, congrats on your mod position here
at orions!
$BDSI-8x34 cross
80% of shares held by institutes and mutual funds. Upcoming PDUFA Oct. 23rd for Belbuca, the company's treatment for moderate to severe chronic pain. The treatment is made in collaboration with Endo International. Has had 2 positive phase III trials. An approval of BELBUCA would trigger a $50 million milestone payment from Endo to BioDelivery and, upon commercialization, would initiate royalty in mid- to high-teens.
LLEN 1.88 Another coal stock ready to go.
SVNT Savient Pharma: Daily Pincher Play
I like this one from your daily pincher list Legend!
Short interest was 45.6% of the float as of May 15th.
Almost half the float is short! Huge short squeeze potential which appears to have started last Friday. Gained 13.16%
Recent trading activity:
Trading in the range of $0.75 - $2.42 in the past 30 days.
SVNT formed a Bullish Engulfing pattern.
Commodity Channel Index (CCI) is bullish for SVNT.
SVNT formed a bullish Stochastic Crossover signal.
A few key tidbits I dug up...
Savient launched gout drug Krystexxa one year ago amid very special circumstances.
1) There was a full two year lag between the end of open enrollment trials and approval so no physicians had been using the drug for a full two years, an uncommon event. This drug needed very heavy educational work and that takes a lot of time and lots of money before gaining traction.
2) The J code necessary for Medicare reimbursement only took effect in January 2012 and it takes a full 6 months for such J codes to work their way into all of the computer systems.
Furthermore, Krystexxa is a drug that has at least 80% of its patients on Medicare. Therefore, traction was never expected before the second quarter that we're now in.
3) Many/most new biotech drugs, especially infused biologics, like Krystexxa, require a lot of spending up front to get going.
4) Krystexxa has orphan protection for 7 years AND patent protection until 2026!
5) Krystexxa is a 100% unencumbered drug. Savient owns 100% worldwide rights.
6) 87.80% of the stock is held by Institutions!
Appears to be way oversold with great turnaround potential.
Going to buy this one and hold for a little while as I see it easily gaining back some of its' recent losses.
Thanks for your charts Legend!
SVNT Stock Analysis
SVNT - Savient Pharmaceuticals, Inc listed on NASDAQ.
SVNT - Sector: Healthcare, Industry: Biotechnology and Drugs.
SVNT gained 13.16% on 05/25/12.
SVNT is trading in the range of $0.75 - $2.42 in the past 30 days.
SVNT formed a Bullish Engulfing pattern.
Commodity Channel Index (CCI) is bullish for SVNT.
SVNT formed a bullish Stochastic Crossover signal.
Our rating on the stock: BULLISH with a score of 4/5.
Free Healthcare!
If you can't afford a doctor, go to an airport - you'll get a free x-ray and a breast exam, and; if you mention Al Qaeda, you'll get a free colonoscopy.
BQI - Libyan chaos ups the importance of Alberta oilsands: British envoy
http://ca.finance.yahoo.com/news/Libyan-chaos-ups-importance-capress-4070702191.html?x=0
LEI - yes kicking myself now.
Wonder how high these low float
oils can go??? before selloff...
LEI - been watching all day.
amazing!!! thinking of buying too.
you first. LOL
DEJ Looks like a little resistance @ .38
but very nice so far!
CNBC reporting $130 oil very possibly.
Lots of gappers this morning.